Marrone Bio Innovations, Inc. (MBII): Price and Financial Metrics

Marrone Bio Innovations, Inc. (MBII): $1.41

0.15 (+11.90%)

POWR Rating

Component Grades













Add MBII to Watchlist
Sign Up

Industry: Chemicals


of 99

in industry


  • MBII scores best on the Sentiment dimension, with a Sentiment rank ahead of 86.89% of US stocks.
  • The strongest trend for MBII is in Growth, which has been heading down over the past 31 weeks.
  • MBII's current lowest rank is in the Value metric (where it is better than 13.46% of US stocks).

MBII Stock Summary

  • With a market capitalization of $233,158,753, Marrone Bio Innovations Inc has a greater market value than only 24.97% of US stocks.
  • As for revenue growth, note that MBII's revenue has grown 31.2% over the past 12 months; that beats the revenue growth of 82.99% of US companies in our set.
  • The volatility of Marrone Bio Innovations Inc's share price is greater than that of 83.62% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to MBII, based on their financial statements, market capitalization, and price volatility, are STIM, BSQR, INSM, SREV, and AUTO.
  • MBII's SEC filings can be seen here. And to visit Marrone Bio Innovations Inc's official web site, go to

MBII Valuation Summary

  • In comparison to the median Basic Materials stock, MBII's price/earnings ratio is 166.38% lower, now standing at -15.2.
  • MBII's price/sales ratio has moved down 26.3 over the prior 97 months.
  • MBII's price/sales ratio has moved down 26.3 over the prior 97 months.

Below are key valuation metrics over time for MBII.

Stock Date P/S P/B P/E EV/EBIT
MBII 2019-11-12 5.2 40.2 -6.1 -7.2
MBII 2018-02-15 2.2 -0.9 -1.2 -3.5
MBII 2016-03-11 3.2 3.5 -0.5 -1.1
MBII 2014-12-01 4.0 0.8 -1.5 -0.6
MBII 2014-11-06 4.6 1.0 -1.7 -0.8
MBII 2013-11-18 41.1 5.8 -7.2 -7.3

MBII Stock Price Chart Interactive Chart >

Price chart for MBII

MBII Price/Volume Stats

Current price $1.41 52-week high $2.90
Prev. close $1.26 52-week low $1.06
Day low $1.26 Volume 568,800
Day high $1.42 Avg. volume 541,752
50-day MA $1.54 Dividend yield N/A
200-day MA $1.64 Market Cap 247.18M

MBII Latest News Stream

Event/Time News Detail
Loading, please wait...

MBII Latest Social Stream

Loading social stream, please wait...

View Full MBII Social Stream

Latest MBII News From Around the Web

Below are the latest news stories about Marrone Bio Innovations Inc that investors may wish to consider to help them evaluate MBII as an investment opportunity.

Marrone Bio Innovations, Inc. (MBII) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Marrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | August 2, 2021

Marrone Bio Innovations to Report Second Quarter 2021 Results on Monday, August 16 at 4:30 p.m. Eastern Time

DAVIS, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the second quarter ended June 30, 2021, after market close on Monday, August 16, 2021 at 4:30 p.m. Eastern time. Management will host an investor conference call at 4:30 p.m. ET (1:30 p.m. PT) on August 16, 2021 to discuss Marron

Yahoo | August 2, 2021

Rizobacter and Marrone Bio Innovations Expand Strategic Alliance to Supply Novel Seed Treatment in Brazil

PERGAMINO, Argentina and DAVIS, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Rizobacter -- a subsidiary of Bioceres Crop Solutions Corp. (NYSE: BIOX) and a global leader in sustainable solutions for agriculture -- and Marrone Bio (NASDAQ: MBII) (MBI) -- an international leader in sustainable bioprotection and plant health solutions -- today announced that Rizonema™, a biological seed treatment for nematodes and soil dwelling insects, will be offered for use in row crops in Brazil through an expande

Yahoo | July 12, 2021

Where Do Hedge Funds Stand On Marrone Bio Innovations Inc (MBII)?

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of March 31st. The results of that effort will be put on display in this article, as […]

Yahoo | June 28, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, traders!

William White on InvestorPlace | June 14, 2021

Read More 'MBII' Stories Here

MBII Price Returns

1-mo -15.06%
3-mo -16.07%
6-mo -27.69%
1-year 21.55%
3-year -31.22%
5-year 76.25%
YTD 12.80%
2020 23.76%
2019 -31.29%
2018 33.64%
2017 -48.60%
2016 94.55%

Continue Researching MBII

Here are a few links from around the web to help you further your research on Marrone Bio Innovations Inc's stock as an investment opportunity:

Marrone Bio Innovations Inc (MBII) Stock Price | Nasdaq
Marrone Bio Innovations Inc (MBII) Stock Quote, History and News - Yahoo Finance
Marrone Bio Innovations Inc (MBII) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8832 seconds.